A New RSV Shot Could Help Protect Babies This Winter — If They Can Get It in Time

Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.


http://dlvr.it/SybjFj

Comments

Popular posts from this blog

Bustos on Bloomberg TV: In Last Two Weeks, “Price of Gas Has Gone Down Forty Cents”